Critical Issues in Clinical Translation of Cutting Edge Cardiovascular Biology
尖端心血管生物学临床转化的关键问题
基本信息
- 批准号:7051705
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-30 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A significant challenge in cardiovascular medicine is to bridge the gap between basic knowledge and clinical applications. This investigator-initiated R13 Conference Grant Application seeks support for a conference whose broad objectivea are to present new information, promote communications, and discuss strategies to bridge this gap in cardiovascular medicine in order to ultimately enhance the care and management of patients with cardiovascular diseases. Critical Issues in Clinical Translation of Cutting Edge Science will convene March 8-11, 2006 in La Jolla, CA. The conference will focus upon topics relevant to implementing cardiovascular regenerative therapies including stem cells, intelligent matrices and molecular approaches.
The conference is organized by the International Society for Applied Cardiovascular Biology (ISACB). The specific aims of the conference are: (1) to address the critical issues in the clinical implementation of cell-based therapies for cardiovascular disease including the potential clinical relevance of stem cell therapies (2) to analyze whether inflammatory processes should be controlled or selectively utilized as therapies (3) to better understand the biology of myocardial and heart valve failure and assess the potential efficacy of cardiovascular tissue engineering strategies for prevention and repair, and (4) to discuss novel molecular approaches to translational cardiovascular research. Attendees at the conference will include basic
researchers, industry scientists, and clinicians and surgeons who treat patients with cardiovascular diseases.
Students in training programs will especially be encouraged to attend. Young Investigator Awards will be presented to student authors of meritorious abstracts. Plenary sessions will include oral presentations by invited speakers, peer-reviewed, proffered papers relevant to the objectives, and discussion. There will be a formal, manned poster session. A "satellite program" preceding the conference will be held on the campus of the University of California San Diego organized by ISACB and Shu Chien, Ph.D., featuring the innovative work of UCSD's Bioengineering Department related to translational cardiovascular research. Cardiovascular
diseases are leading causes of death in the United States and throughout the world. Novel treatment approaches rooted in the understanding and selective utilization of basic biology are critical. It is anticipated that this conference will have high scientific and clinical merit and relevance.
心血管医学的一个重大挑战是弥合基础知识和临床应用之间的差距。这是一个由赞助商发起的R13会议资助申请,旨在支持一个会议,该会议的广泛目标是提供新信息,促进沟通,并讨论弥合心血管医学差距的策略,以最终加强对心血管疾病患者的护理和管理。尖端科学临床翻译中的关键问题将于2006年3月8日至11日在加利福尼亚州的拉霍亚召开。会议将重点讨论与实施心血管再生疗法相关的主题,包括干细胞,智能基质和分子方法。
该会议由国际应用心血管生物学学会(ISACB)组织。会议的具体目标是:(1)解决基于细胞的心血管疾病治疗的临床实施中的关键问题,包括干细胞治疗的潜在临床相关性(2)分析炎症过程是否应该控制或选择性地用作治疗(3)为了更好地理解心肌和心脏瓣膜衰竭的生物学并评估心血管组织工程策略用于预防和修复的潜在功效,(4)探讨心血管转化研究的新分子途径。与会者将包括基本的
研究人员、行业科学家以及治疗心血管疾病患者的临床医生和外科医生。
特别鼓励参加培训课程的学生参加。青年研究者奖将颁发给优秀摘要的学生作者。全体会议将包括受邀演讲者的口头报告、同行评审、与目标相关的论文以及讨论。将有一个正式的,载人海报会议。会议前的“卫星计划”将在加州圣地亚哥大学校园举行,由ISACB和Shu Chien博士组织,该展览展示了加州大学圣地亚哥分校生物工程系与转化型心血管研究相关的创新工作。心血管
疾病是美国和全世界的主要死亡原因。基于对基础生物学的理解和选择性利用的新型治疗方法至关重要。预计这次会议将具有很高的科学和临床价值和相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOWARD P GREISLER其他文献
HOWARD P GREISLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOWARD P GREISLER', 18)}}的其他基金
GROWTH FACTOR MEDIATION OF HEALING OF VASCULAR GRAFTS
生长因子对血管移植物愈合的调节
- 批准号:
2219950 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
GROWTH FACTOR MEDIATION OF HEALING OF VASCULAR GRAFTS
生长因子对血管移植物愈合的调节
- 批准号:
6125765 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
Growth Factor Mediation of Healing of Vascular Grafts
生长因子介导血管移植物的愈合
- 批准号:
7072621 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
GROWTH FACTOR MEDIATION OF HEALING OF VASCULAR GRAFTS
生长因子对血管移植物愈合的调节
- 批准号:
2487329 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
GROWTH FACTOR MEDIATION OF HEALING OF VASCULAR GRAFTS
生长因子对血管移植物愈合的调节
- 批准号:
3358932 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
GROWTH FACTOR MEDIATION OF HEALING OF VASCULAR GRAFTS
生长因子对血管移植物愈合的调节
- 批准号:
949594 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
GROWTH FACTOR MEDIATION OF HEALING OF VASCULAR GRAFTS
生长因子对血管移植物愈合的调节
- 批准号:
3358931 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
GROWTH FACTOR MEDIATION OF HEALING OF VASCULAR GRAFTS
生长因子对血管移植物愈合的调节
- 批准号:
6330034 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
Growth Factor Mediation of Healing of Vascular Grafts
生长因子介导血管移植物的愈合
- 批准号:
6805629 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
GROWTH FACTOR MEDIATION OF HEALING OF VASCULAR GRAFTS
生长因子对血管移植物愈合的调节
- 批准号:
3358929 - 财政年份:1988
- 资助金额:
$ 1万 - 项目类别:
相似海外基金
Harm and benefit of second and third generation beta1-blockers on placental vascular function, fetal growth and fetal cardiovascular function.
第二代和第三代β1受体阻滞剂对胎盘血管功能、胎儿生长和胎儿心血管功能的危害和益处。
- 批准号:
MR/X007170/1 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Fellowship
The adverse impact of prenatal cannabinoid exposure on placental and postnatal cardiovascular function: can we intervene?
产前接触大麻素对胎盘和产后心血管功能的不利影响:我们可以干预吗?
- 批准号:
462398 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Operating Grants
The role of estrogen receptors in cardiovascular function
雌激素受体在心血管功能中的作用
- 批准号:
RGPIN-2018-04732 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Discovery Grants Program - Individual
Impact of birth weight and intestinal fat on the cardiovascular function of school children
出生体重和肠道脂肪对学龄儿童心血管功能的影响
- 批准号:
21K07876 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
All-Extremity Exercise as a Novel Strategy for Optimizing Cardiovascular Function during Chemotherapy for Breast Cancer
全肢运动作为乳腺癌化疗期间优化心血管功能的新策略
- 批准号:
10418617 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
The role of estrogen receptors in cardiovascular function
雌激素受体在心血管功能中的作用
- 批准号:
RGPIN-2018-04732 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Discovery Grants Program - Individual
Repurposing the FDA-approved antibiotic sulfaphenazole for neuroprotection post spinal cord injury to improve motor and cardiovascular function
重新利用 FDA 批准的抗生素磺胺苯唑用于脊髓损伤后的神经保护,以改善运动和心血管功能
- 批准号:
459039 - 财政年份:2021
- 资助金额:
$ 1万 - 项目类别:
Studentship Programs
Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock
血管趋化因子受体对创伤失血性休克后心血管功能的贡献
- 批准号:
10091901 - 财政年份:2020
- 资助金额:
$ 1万 - 项目类别:
Contributions of vascular chemokine receptors to cardiovascular function after traumatic-hemorrhagic shock
血管趋化因子受体对创伤失血性休克后心血管功能的贡献
- 批准号:
10641113 - 财政年份:2020
- 资助金额:
$ 1万 - 项目类别:
Lactation, Oxytocin and Maternal Cardiovascular Function.
哺乳期、催产素和母亲心血管功能。
- 批准号:
10774048 - 财政年份:2020
- 资助金额:
$ 1万 - 项目类别: